252 related articles for article (PubMed ID: 34159715)
1. Functional avoidance-based intensity modulated proton therapy with 4DCT derived ventilation imaging for lung cancer.
Dougherty JM; Castillo E; Castillo R; Faught AM; Pepin M; Park SS; Beltran CJ; Guerrero T; Grills I; Vinogradskiy Y
J Appl Clin Med Phys; 2021 Jul; 22(7):276-285. PubMed ID: 34159715
[TBL] [Abstract][Full Text] [Related]
2. Spot scanning proton arc therapy reduces toxicity in oropharyngeal cancer patients.
de Jong BA; Battinelli C; Free J; Wagenaar D; Engwall E; Janssens G; Langendijk JA; Korevaar EW; Both S
Med Phys; 2023 Mar; 50(3):1305-1317. PubMed ID: 36373893
[TBL] [Abstract][Full Text] [Related]
3. Training and validation of a knowledge-based dose-volume histogram predictive model in the optimisation of intensity-modulated proton and volumetric modulated arc photon plans for pleural mesothelioma patients.
Franceschini D; Cozzi L; Fogliata A; Marini B; Di Cristina L; Dominici L; Spoto R; Franzese C; Navarria P; Comito T; Reggiori G; Tomatis S; Scorsetti M
Radiat Oncol; 2022 Aug; 17(1):150. PubMed ID: 36028862
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric feasibility of 4DCT-ventilation imaging guided proton therapy for locally advanced non-small-cell lung cancer.
Huang Q; Jabbour SK; Xiao Z; Yue N; Wang X; Cao H; Kuang Y; Zhang Y; Nie K
Radiat Oncol; 2018 Apr; 13(1):78. PubMed ID: 29695284
[TBL] [Abstract][Full Text] [Related]
5. Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with hodgkin's lymphoma. Assessment of risk of toxicity and secondary cancer induction.
Scorsetti M; Cozzi L; Navarria P; Fogliata A; Rossi A; Franceschini D; De Rose F; Franzese C; Carlo-Stella C; Santoro A
Radiat Oncol; 2020 Jan; 15(1):12. PubMed ID: 31931861
[TBL] [Abstract][Full Text] [Related]
6. Small-spot intensity-modulated proton therapy and volumetric-modulated arc therapies for patients with locally advanced non-small-cell lung cancer: A dosimetric comparative study.
Liu C; Sio TT; Deng W; Shan J; Daniels TB; Rule WG; Lara PR; Korte SM; Shen J; Ding X; Schild SE; Bues M; Liu W
J Appl Clin Med Phys; 2018 Nov; 19(6):140-148. PubMed ID: 30328674
[TBL] [Abstract][Full Text] [Related]
7. Organ sparing potential and inter-fraction robustness of adaptive intensity modulated proton therapy for lung cancer.
van der Laan HP; Anakotta RM; Korevaar EW; Dieters M; Ubbels JF; Wijsman R; Sijtsema NM; Both S; Langendijk JA; Muijs CT; Knopf AC
Acta Oncol; 2019 Dec; 58(12):1775-1782. PubMed ID: 31556764
[No Abstract] [Full Text] [Related]
8. Towards the clinical implementation of intensity-modulated proton therapy for thoracic indications with moderate motion: Robust optimised plan evaluation by means of patient and machine specific information.
Ribeiro CO; Visser S; Korevaar EW; Sijtsema NM; Anakotta RM; Dieters M; Both S; Langendijk JA; Wijsman R; Muijs CT; Meijers A; Knopf A
Radiother Oncol; 2021 Apr; 157():210-218. PubMed ID: 33545257
[TBL] [Abstract][Full Text] [Related]
9. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
[TBL] [Abstract][Full Text] [Related]
10. Volumetric modulated arc therapy versus intensity-modulated proton therapy in neoadjuvant irradiation of locally advanced oesophageal cancer.
Celik E; Baus W; Baues C; Schröder W; Clivio A; Fogliata A; Scorsetti M; Marnitz S; Cozzi L
Radiat Oncol; 2020 May; 15(1):120. PubMed ID: 32448296
[TBL] [Abstract][Full Text] [Related]
11. Sparing Cardiac Substructures With Optimized Volumetric Modulated Arc Therapy and Intensity Modulated Proton Therapy in Thoracic Radiation for Locally Advanced Non-small Cell Lung Cancer.
Ferris MJ; Martin KS; Switchenko JM; Kayode OA; Wolf J; Dang Q; Press RH; Curran WJ; Higgins KA
Pract Radiat Oncol; 2019; 9(5):e473-e481. PubMed ID: 31077884
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated proton and carbon-ion radiotherapy using a fixed-beam system for locally advanced lung cancer: dosimetric comparison with x-ray radiotherapy and normal tissue complication probability (NTCP) evaluation.
Ming X; Mao J; Ma N; Chen J; Wang W; Sheng Y; Wu K
Phys Med Biol; 2024 Jan; 69(1):. PubMed ID: 38064747
[No Abstract] [Full Text] [Related]
13. Bone marrow sparing in prostate cancer patients treated with Post-operative pelvic nodal radiotherapy - A proton versus photon comparison.
De Ornelas M; Iorio GC; Bossart E; Ricardi U; Seldon C; Dal Pra A; Butkus M
Phys Med; 2023 Aug; 112():102644. PubMed ID: 37487297
[TBL] [Abstract][Full Text] [Related]
14. Dose-volume comparison of intensity modulated proton therapy and volumetric modulated arc therapy for cervical esophageal cancer.
Kato T; Ono T; Narita Y; Komori S; Murakami M
Med Dosim; 2022 Autumn; 47(3):216-221. PubMed ID: 35346554
[TBL] [Abstract][Full Text] [Related]
15. Intensity Modulated Proton Therapy Better Spares Non-Adjacent Organs and Reduces the Risk of Secondary Malignant Neoplasms in the Treatment of Sinonasal Cancers.
Lewis L; Kreinbrink P; Richardson M; Westerfield M; Doberstein M; Zhang Y; Redmond K; Takiar V
Med Dosim; 2022 Summer; 47(2):117-122. PubMed ID: 34952761
[TBL] [Abstract][Full Text] [Related]
16. Comparison of photon volumetric modulated arc therapy, intensity-modulated proton therapy, and intensity-modulated carbon ion therapy for delivery of hypo-fractionated thoracic radiotherapy.
Chi A; Lin LC; Wen S; Yan H; Hsi WC
Radiat Oncol; 2017 Aug; 12(1):132. PubMed ID: 28810881
[TBL] [Abstract][Full Text] [Related]
17. Volumetric modulated arc therapy versus intensity-modulated proton therapy in the postoperative irradiation of thymoma.
Franceschini D; Cozzi L; Loi M; Franzese C; Reggiori G; Mancosu P; Clivio A; Fogliata A; Scorsetti M
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2267-2276. PubMed ID: 32514629
[TBL] [Abstract][Full Text] [Related]
18. Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head.
Raturi VP; Hojo H; Hotta K; Baba H; Takahashi R; Rachi T; Nakamura N; Zenda S; Motegi A; Tachibana H; Ariji T; Motegi K; Nakamura M; Okumura M; Hirano Y; Akimoto T
Radiat Oncol; 2020 Jun; 15(1):157. PubMed ID: 32571379
[TBL] [Abstract][Full Text] [Related]
19. Robustness assessment of clinical adaptive proton and photon radiotherapy for oesophageal cancer in the model-based approach.
Visser S; O Ribeiro C; Dieters M; Mul VE; Niezink AGH; van der Schaaf A; Knopf AC; Langendijk JA; Korevaar EW; Both S; Muijs CT
Radiother Oncol; 2022 Dec; 177():197-204. PubMed ID: 36368472
[TBL] [Abstract][Full Text] [Related]
20. The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-Escalation.
Cozzi L; Comito T; Loi M; Fogliata A; Franzese C; Franceschini D; Clerici E; Reggiori G; Tomatis S; Scorsetti M
Technol Cancer Res Treat; 2020; 19():1533033820980412. PubMed ID: 33287650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
